Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

NCT: NCT04674969 · RECRUITING

NCT IDNCT04674969
StatusRECRUITING
Start Date2021-03-29
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑